
François Lauzier
Chercheur universitaire clinicien
Axe Santé des populations et pratiques optimales en santé
Dernières nouvelles
Voir tout
Communiqués
Une plateforme internationale adaptative d’essais cliniques sur les traumatismes craniocérébraux novatrice financée à hauteur de 4,8 M $

Communiqués
IRSC : Un financement de plus de 11 millions de dollars pour 15 projets de recherche

Nouvelles
[ULaval Nouvelles] Soins aux victimes de traumatismes graves: des écarts préoccupants entre hôpitaux
Publications
Voir tout-
article Takaoka A, Johnstone J, Lauzier F, Heels-Ansdell D, Davis M, Zytaruk N, Duan E, Dionne J, Saunders L, Arabi YM, Marshall J, Thabane L, Clarke F, Hand L, Masse MH, Rochwerg B, McIntyre L, Girard M, Freitag A, Karachi T, Cook DJ and and
Enrolment patterns in a randomized controlled trial of probiotics in critically ill patients: a retrospective analysis of the PROSPECT trial
Trials 25 (1), 2024.
-
article Wang Y, Heels-Ansdell D, Ge L, Parpia S, Ibrahim Q, Cook D, Deane A, Lauzier F, Hammond N, Møller MH, Krag M, Perner A, Guyatt GH
Proton pump inhibitors for gastrointestinal bleeding prophylaxis in critically ill patients: A systematic review protocol
Acta Anaesthesiol Scand 68 (7), 2024.
-
article Cook D, Deane A, Dionne JC, Lauzier F, Marshall JC, Arabi YM, Wilcox ME, Ostermann M, Al-Fares A, Heels-Ansdell D, Zytaruk N, Thabane L, Finfer S and
Adjudication of a primary trial outcome: Results of a calibration exercise and protocol for a large international trial
Contemp Clin Trials Commun 39 2024.
Projets
- Canadian Traumatic brain injury Research Consortium, du 2015-12-01 au 2025-03-31
- The Ottawa SHA search algorithm : a novel and innovative primary subarachnoïd hemorrhage prediction model using health administrative data : facilitating large-scale population -based epidemiologic studies., du 2017-05-17 au 2025-03-31
- Anticoagulation and Convalescent Plasma ICU Trials in REMAP-CAP, du 2020-06-01 au 2025-03-31
- Development of Interdisciplinary Strategies to Prevent Chronic Opioid Use in Adult Trauma Patients, du 2021-04-01 au 2026-03-31
- Improving the quality of Canadian pediatric injury care: identifying priorities based on evidence, practice variations and stakeholder needs and preferences, du 2021-10-01 au 2025-09-30
- Reducing low-value practices in acute trauma care: a pragmatic cluster randomized controlled trial, du 2023-04-01 au 2027-03-31
- activated CHARcoal in Poisoned Patients (CHARPP): a pilot Randomized Controlled Trial, du 2023-04-01 au 2026-03-31
- BRAINapt: TBI International Adaptive Platform Trial, du 2024-04-01 au 2029-03-31
- Improving mental health pratices recovering from traumatic injuries: Identifying prioritiez based on knowledge to practice gaps and interested parties needs and preferences, du 2024-04-01 au 2028-03-31
- BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections, du 2022-09-01 au 2025-03-31
- Audit & Feedback Module Targeting Low-Value Clinical Practices in Injury Care: an Economic Evaluation, du 2020-04-01 au 2023-03-31
- PROphylaxis for venous ThromboEmbolism in Severe Traumatic brain injury (PROTEST): a Double-blind Randomized Controlled trial, du 2018-10-01 au 2023-09-30
- The NeurO2 study: optimal brain oxygenation in neurocritically ill patients, du 2020-10-01 au 2024-03-31
- Calcineurin Inhibitor in NEuRoloGically deceased donors to decrease kidney delaYed graft function trial (CINERGY) - Vanguard, du 2021-04-01 au 2023-09-30
- Fluids in Septic Shock (FISSH): a randomized controlled trial., du 2020-04-01 au 2023-11-30
- BRAINapt: TBI International Platform Trial, du 2023-10-01 au 2024-03-31